Measurement of indocyanine green plasma disappearance rate by two different dosages

Yazar: Sakka, S, Koeck, H, Meier-Hellmann, A
Baskı/Yayın Bilgisi 2004

Prognostic value of indocyanine green-plasma disappearance rate in critically ill patients

Yazar: Sakka, SG, Meier-Hellmann, A, Reinhart, K
Baskı/Yayın Bilgisi 2002

Usefulness of intrathoracic blood volume in the early phase of hemodynamic instability of patients with sepsis or septic shock

Yazar: Sakka, SG, Meier-Hellmann, A, Reinhart, K
Baskı/Yayın Bilgisi 1999

Assessment of intrathoracic blood volume and extravascular lung water by single transpulmonary thermodilution

Yazar: Sakka, SG, Meier-Hellmann, A, Reinhart, K
Baskı/Yayın Bilgisi 1999

Procalcitonin — A new indicator of the systemic response to severe infections

Yazar: Karzai, W., Oberhoffer, M., Meier-Hellmann, A., Reinhart, K.
Yayımlandı Infection (1997)

Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream

Yazar: Samet, A., Śledzińska, A., Krawczyk, B., Hellmann, A., Nowicki, S., Kur, J., Nowicki, B.
Baskı/Yayın Bilgisi 2013

A new questionnaire to determine the effect of team interaction in the ICU on perceived futility and intention to quit: results of a pilot study in two German hospitals

Yazar: Schwarzkopf, D, Bloos, F, Meier-Hellmann, A, Icke, C, Riedemann, N, Hartog, CS
Baskı/Yayın Bilgisi 2014

Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)

Yazar: Riess, H, Meier-Hellmann, A, Motsch, J, Elias, M, Kursten, F, Dempfle, C
Baskı/Yayın Bilgisi 2007

Increased monocyte activation and tissue factor expression in patients with sepsis

Yazar: Dohrn, B, Russwurm, S, Vickers, J, Meier-Hellmann, A, Spangenberg, P, Lösche , W, Reinhart, K
Baskı/Yayın Bilgisi 1998

Platelets and platelet-activating factor acetylhydrolase in septic patients

Yazar: Ruβwurm, S, Dohrn, B, Oberhoffer, M, Meier-Hellmann, A, Krause, S, Lösche, W, Reinhart, K
Baskı/Yayın Bilgisi 1999

A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management

Yazar: VALENTINO, L A, MAMONOV, V, HELLMANN, A, QUON, D V, CHYBICKA, A, SCHROTH, P, PATRONE, L, WONG, W-Y
Baskı/Yayın Bilgisi 2012

A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients

Yazar: Schädler, D, Porzelius, C, Jörres, A, Marx, G, Meier-Hellmann, A, Putensen, C, Quintel, M, Spies, C, Engel, C, Weiler, N, Kuhlmann, M
Baskı/Yayın Bilgisi 2013

Clinical assessment of Optivate(®), a high‐purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

Yazar: DMOSZYNSKA, A., KULICZKOWSKI, K., HELLMANN, A., TRELINSKI, J., KLOCZKO, J., BAGLIN, T., HAY, C., O’SHAUGHNESSY, D., ZAWILSKA, K., MAKRIS, M., SHAIKH‐ZAIDI, R., GASCOIGNE, E., DASH, C.
Yayımlandı Haemophilia (2011)

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

Yazar: Hus, I, Dmoszynska, A, Manko, J, Hus, M, Jawniak, D, Soroka-Wojtaszko, M, Hellmann, A, Ciepluch, H, Skotnicki, A, Wolska-Smolen, T, Sulek, K, Robak, T, Konopka, L, Kloczko, J
Baskı/Yayın Bilgisi 2004

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

Yazar: Hochhaus, A, Masszi, T, Giles, F J, Radich, J P, Ross, D M, Gómez Casares, M T, Hellmann, A, Stentoft, J, Conneally, E, García-Gutiérrez, V, Gattermann, N, Wiktor-Jedrzejczak, W, le Coutre, P D, Martino, B, Saussele, S, Menssen, H D, Deng, W, Krunic, N, Bedoucha, V, Saglio, G
Yayımlandı Leukemia (2017)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

Yazar: Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Yayımlandı Leukemia (2016)

Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German I...

Yazar: Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C.-E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., Kern, W., Kreymann, G., Krüger, W., Kujath, P., Marggraf, G., Martin, J., Mayer, K., Meier-Hellmann, A., Oppert, M., Putensen, C., Quintel, M., Ragaller, M., Rossaint, R., Seifert, H., Spies, C., Stüber, F., Weiler, N., Weimann, A., Werdan, K., Welte, T.
Baskı/Yayın Bilgisi 2010

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

Yazar: Gratwohl, A, Pfirrmann, M, Zander, A, Kröger, N, Beelen, D, Novotny, J, Nerl, C, Scheid, C, Spiekermann, K, Mayer, J, Sayer, H G, Falge, C, Bunjes, D, Döhner, H, Ganser, A, Schmidt-Wolf, I, Schwerdtfeger, R, Baurmann, H, Kuse, R, Schmitz, N, Wehmeier, A, Th Fischer, J, Ho, A D, Wilhelm, M, Goebeler, M-E, Lindemann, H W, Bormann, M, Hertenstein, B, Schlimok, G, Baerlocher, G M, Aul, C, Pfreundschuh, M, Fabian, M, Staib, P, Edinger, M, Schatz, M, Fauser, A, Arnold, R, Kindler, T, Wulf, G, Rosselet, A, Hellmann, A, Schäfer, E, Prümmer, O, Schenk, M, Hasford, J, Heimpel, H, Hossfeld, D K, Kolb, H-J, Büsche, G, Haferlach, C, Schnittger, S, Müller, M C, Reiter, A, Berger, U, Saußele, S, Hochhaus, A, Hehlmann, R
Yayımlandı Leukemia (2016)